A detailed history of New Edge Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, New Edge Wealth, LLC holds 44,221 shares of ABBV stock, worth $7.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
44,221
Previous 46,385 4.67%
Holding current value
$7.4 Million
Previous $7.19 Million 12.02%
% of portfolio
0.18%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $345,850 - $394,064
-2,164 Reduced 4.67%
44,221 $8.05 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $5.64 Million - $6.35 Million
-40,992 Reduced 46.91%
46,385 $7.19 Million
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $1.16 Million - $1.34 Million
8,675 Added 11.02%
87,377 $13 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $1.7 Million - $2.11 Million
12,823 Added 19.46%
78,702 $10.6 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $251,476 - $289,613
1,739 Added 2.71%
65,879 $10.5 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $834,839 - $1 Million
6,036 Added 10.39%
64,140 $10.4 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $7,918 - $9,081
59 Added 0.1%
58,104 $7.8 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $3.31 Million - $4.21 Million
24,066 Added 70.83%
58,045 $8.89 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $4.09 Million - $5.07 Million
30,981 Added 1033.39%
33,979 $5.51 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $64,350 - $81,422
599 Added 24.97%
2,998 $406,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $8,405 - $9,541
79 Added 3.41%
2,399 $259,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $244,087 - $271,927
2,320 New
2,320 $261,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.